Page last updated: 2024-10-28

hydroxychloroquine and Cervix Dysplasia

hydroxychloroquine has been researched along with Cervix Dysplasia in 2 studies

Hydroxychloroquine: A chemotherapeutic agent that acts against erythrocytic forms of malarial parasites. Hydroxychloroquine appears to concentrate in food vacuoles of affected protozoa. It inhibits plasmodial heme polymerase. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, p970)
hydroxychloroquine : An aminoquinoline that is chloroquine in which one of the N-ethyl groups is hydroxylated at position 2. An antimalarial with properties similar to chloroquine that acts against erythrocytic forms of malarial parasites, it is mainly used as the sulfate salt for the treatment of lupus erythematosus, rheumatoid arthritis, and light-sensitive skin eruptions.

Research Excerpts

ExcerptRelevanceReference
"Methods We identified systemic lupus erythematosus patients initiating immunosuppressive drugs or hydroxychloroquine using claims data from two US commercial health plans and Medicaid (2000-2012)."1.46Risk of high-grade cervical dysplasia and cervical cancer in women with systemic lupus erythematosus receiving immunosuppressive drugs. ( Feldman, CH; Feldman, S; Kim, SC; Liu, J; Solomon, DH, 2017)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Thimm, MA1
Rositch, AF1
VandenBussche, C1
McDonald, L1
Garonzik Wang, JM1
Levinson, K1
Feldman, CH1
Liu, J1
Feldman, S1
Solomon, DH1
Kim, SC1

Other Studies

2 other studies available for hydroxychloroquine and Cervix Dysplasia

ArticleYear
Lower Genital Tract Dysplasia in Female Solid Organ Transplant Recipients.
    Obstetrics and gynecology, 2019, Volume: 134, Issue:2

    Topics: Adult; Early Detection of Cancer; Female; Genital Neoplasms, Female; Humans; Hydroxychloroquine; Inc

2019
Risk of high-grade cervical dysplasia and cervical cancer in women with systemic lupus erythematosus receiving immunosuppressive drugs.
    Lupus, 2017, Volume: 26, Issue:7

    Topics: Adult; Algorithms; Cohort Studies; Female; Humans; Hydroxychloroquine; Immunosuppressive Agents; Lup

2017